Someone please correct me if I am wrong. I am assuming the French AT LEAST are tinkering with dangerous viral combinations in a ‘bio hazard level 4’ facility. I am assuming that a P4 maximum security laboratory means level 4? A level six would make much more sense. Level 4 is not the best but certainly is a better bio hazard security lab then in America where companies ADMIT the same kinds of dangerous viral experimentation are going on at college campuses!
In the above article a worker suing Pfizer accuses the company of ‘recklessly’ creating GM viruses. Creating viruses potentially MUCH MORE DANGEROUS then what the French are doing in a Bio level 4 facility. I would like to note that Pfizer does NOT deny their screwing around with G.M. viruses, but their Bozo spokes person says… “No big deal, college campuses are doing it all the time.” I am sorry to have to inform you, NO, it is a ‘big deal’.
Special Thanks to Lab Virus dot com.
In Lyon we try to cross the H1N1 virus and influenza H5N1de
by Olivier Season
In the P4, a maximum security laboratory, an experiment in progress attempts to determine the conditions for hybridization of the two viruses. The first is spreading fast but few kills, the second is not contagious but often fatal
For three weeks, the P4 Lyon stopped all other manipulations. This maximum security laboratory – there is only in France and twenty in the world – is currently focusing on experience in high-risk attempts to cross between the new virus and the H1N1 avian influenza, the H5N1. The first spread far and few kills, the second low spreads and kills many. Hybridization of the two would be disastrous.
“We try to understand, by infecting a cell with these two viruses, which are the genetic determinants that allow them to exchange genes (especially in pigs Ed)” summarizes the virologist Bruno Lina, who heads the work on influenza A for this laboratory Inserm. Three biologists of his team have been seconded to perform these tests determined and endorsed at ministerial level. Provided with special passports, they are assisted by a half-dozen technicians attached to the site. “All operations are diving and are subject to very restrictive regulations” provides Lina.
If experience is linked to the National Reference Center for influenza virus, that it manages, its purpose would, in his opinion, not lead to a vaccine, but just “cognitive”: “Why make a vaccine against a virus that does not exist? Or not. The first results will fall within two months and decide the action to the operation budget (provisional) 200 000. For now, “we made some tests, but obtained only very preliminary results,” continues the virologist. If it is too early to deduce anything about the likelihood of the emergence of such a viral monster, “today, the risk seems low,” says he. He concluded: “This is good news.”